옵션 체인은 다양한 행사가격과 만기일에 대한 Lion Electric의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Lion Electric에 대한 시장 심리를 평가합니다..

Lion Electric (NYSE:LEV) 주식, 옵션 체인

Lion Electric

The Lion Electric Co. includes designing, developing, manufacturing and distributing purpose-built all-electric medium and heavy-duty urban vehicles including battery systems, chassis, bus bodies and truck cabins. The Group also distributes truck and bus parts and accessories. The Group has one reportable operating segment, the manufacturing and sales of electric vehicles in Canada and in the United States. Geographically, the majority of revenue is generated from Canada.

News

Movers

라이온 일렉트릭(NYSE:LEV)의 주식이 월요일 55% 이상 급등했다. 이 회사는 선순위 신용용 상품에 대한 수정과 인력 감축을 발표했다. 여기 알아야 할 사항이 있다.

라이온 일렉트릭 주식이 월요일 55% 이상 급등: 무슨 일이?

The Lion Electric Co

The Lion Electric Company Warrants to purchase common shares

Levi Strauss & Co

Levolution

Through this existing collaboration, Evonik's proprietary biodegradable long-acting PLGA (RESOMER) microparticle formulation was used for SIL-204, Silexion's next-generation siRNA candidate. This innovative formulation has demonstrated high efficacy in preclinical models using mice with human pancreatic tumor cell lines carrying various KRAS mutations. By leveraging Evonik's formulation expertise, Silexion aims to deliver sustained-release RNAi therapy, allowing for more effective targeting of KRAS mutations—one of the most challenging genetic drivers in oncology.

Biotech

Health Care

General

SLXN

Silexion Therapeutics Revealed Its Ongoing Collaboration With Evonik For The Development Of An Advanced siRNA Formulation Aimed At Enhancing Cancer Treatment Efficacy

Affimed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) ("Affimed," or the "Company"), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced updated clinical data from the ongoing AFM24-102 trial of AFM24/atezolizumab combination therapy in heavily pretreated NSCLC patients. Results continue to demonstrate meaningful clinical activity in both NSCLC EGFRwt and EGFRmut patients with good tolerability. In addition, the Company reported findings from a post-hoc exposure-response analysis in patients treated with 480 mg AFM24 showing higher AFM24 exposure is associated with significantly better response rates, improved PFS and overall survival (OS). Based on these data, the future development program for AFM24 will use a dose of 720 mg weekly, a dose that has already been successfully tested in the phase 1 study of AFM24 showing a manageable safety profile.

AFMD

Affimed Reports Results for Cancer Therapy in NSCLC Patients

Management

Brazil Potash Appoints Mayo Schmidt As Executive Chairman Of Its Board, Effective January 6, 2025

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHTX#NASDAQ">FHTX</a>) with a Buy and lowers the price target from $20 to $13.

Price Target

Reiteration

Analyst Ratings

FHTX

HC Wainwright & Co. Reiterates Buy on Foghorn Therapeutics, Lowers Price Target to $13

Jefferies analyst Omar Nokta maintains Frontline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) with a Buy and lowers the price target from $26 to $20.

Jefferies Maintains Buy on Frontline, Lowers Price Target to $20

Morgan Stanley analyst Angel Castillo upgrades WillScot Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) from Equal-Weight to Overweight and raises the price target from $40 to $50.

Upgrades

Morgan Stanley Upgrades WillScot Holdings to Overweight, Raises Price Target to $50

Jefferies analyst Omar Nokta maintains Hafnia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAFN#NYSE">HAFN</a>) with a Buy and lowers the price target from $8 to $6.5.

HAFN

Jefferies Maintains Buy on Hafnia, Lowers Price Target to $6.5

Guidance

Merrill Lynch & Strategic Return Notes for Select 10 Index

Reported Earlier, Maison Solutions Reiterates FY25 Guidance: Revenues $120M - $125M, Net Income Positive

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Annexon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) with a Buy and maintains $30 price target.

ANNX

HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target

Insider Trades

FREY

FREYR Battery CFO Calio Reported Purchase Of 549,862 Shares @ Average Price Of $1.64 In Form 4 Filing on Monday

Jefferies analyst Omar Nokta maintains ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) with a Hold and lowers the price target from $28 to $22.

Jefferies Maintains Hold on ZIM Integrated Shipping, Lowers Price Target to $22

Earnings

Reported Earlier, Maison Solutions Q2 EPS $(0.01) Down From $0.01 YoY, Sales $31.02M Up From $13.77M YoY

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) with a Buy and maintains $13 price target.

FENC

HC Wainwright & Co. Reiterates Buy on Fennec Pharmaceuticals, Maintains $13 Price Target

Seaport Global analyst Laurie Havener Hunsicker upgrades Berkshire Hills Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHLB#NYSE">BHLB</a>) from Neutral to Buy and announces $39 price target.

BHLB

Seaport Global Upgrades Berkshire Hills Bancorp to Buy, Announces $39 Price Target

Morgan Stanley analyst Angel Castillo upgrades CNH Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNH#NYSE">CNH</a>) from Equal-Weight to Overweight and raises the price target from $11 to $16.5.

Morgan Stanley Upgrades CNH Industrial to Overweight, Raises Price Target to $16.5

HC Wainwright &amp; Co. analyst Raghuram Selvaraju downgrades CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) from Buy to Neutral.

Downgrades

CRVO

HC Wainwright & Co. Downgrades CervoMed to Neutral

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Biohaven (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) with a Buy and maintains $59 price target.

BHVN

HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $59 Price Target

Morgan Stanley analyst Meta Marshall downgrades CommScope Hldg Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) from Equal-Weight to Underweight and maintains the price target from $5 to $5.

COMM

Morgan Stanley Downgrades CommScope Hldg Co to Underweight, Maintains Price Target to $5

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) with a Buy and maintains $12 price target.

DARE

HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

Morgan Stanley analyst Meta Marshall downgrades Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) from Equal-Weight to Underweight and raises the price target from $8 to $9.5.

VIAV

Morgan Stanley Downgrades Viavi Solutions to Underweight, Raises Price Target to $9.5

Analyst George Gianarikas of Canaccord Genuity maintained a Hold rating on Lion Electric Company (LEV – Research Report), with a price target of $0...

Lion Electric Faces Production Challenges and Uncertain Liquidity Amid Hold Rating

Lion Electric Company (LEV) has released an update. Lion Electric Company has announced amendments to its senior credit agreements in an effort to ...

Lion Electric Faces Financial Challenges Amid Credit Amendments

NYSE commences delisting proceedings of Lion Electric warrants

Lion Electric Company (LEV) has released an update. The Lion Electric Company faces delisting proceedings for its warrants on the NYSE due to low s...

Lion Electric Faces NYSE Delisting of Warrants

Lion Electric (LEV) is fast approaching a deadline this weekend to find new investors amid a cash crunch and an EV market that's in turmoil, Bloomb...

Lion Electric approaches creditor deadline, Bloomberg reports

Lion Electric Company (LEV) has released an update. Lion Electric Company is taking significant steps to address its financial challenges by amendi...

Lion Electric Restructures Finances and Workforce

Lion Electric surges after getting a temporary reprieve from its creditors

The Lion Electric (LEV) Company announced that it has reached a definitive agreement with Aeroport de Montreal to sell its innovation center facili...

Lion Electric agrees to sell innovation center facility to Aeroport de Montreal

Lion Electric Company (LEV) has released an update. Lion Electric Company has announced the sale of its innovation center in Mirabel, Québec to Aér...

Lion Electric Sells Innovation Center to Reduce Debt

EV Company News For The Month Of November 2024

AYRO

BAMXF

BATT

BCCMY

BLBD

BLNK

BMCLF

BYDDF

BYDDY

BYMOF

DNFGF

DNFGY

EVGO

EVGOW

EVTV

FUJHF

FUJHY

GELYF

GELYY

GOEV

GOEVW

GWLLF

GWLLY

HNDAF

HYLN

HYMTF

KNDI

LAAOF

LCID

MAHMF

MBGAF

MBGYY

MMTOF

MZDAF

MZDAY

NIOIF

NSANF

NSANY

POAHF

POAHY

PSNY

PSNYW

RACE

RIVN

RNLSY

RNSDF

STLA

SZKMF

SZKMY

TOYOF

TSLA

VFSWW

VLKAF

VLKPF

VWAGY

VWAPY

WKHS

XIACF

XIACY

XPEV

XPNGF

Commodities

Press Releases

LION ELECTRIC ANNOUNCES SECOND QUARTER 2024 RESULTS

LION ELECTRIC'S SCHOOL BUSES ARE NOW ELIGIBLE FOR DOMINION ENERGY'S ELECTRIC SCHOOL BUS INFRASTRUCTURE PROGRAM IN VIRGINIA

LION ELECTRIC ANNOUNCES ADDITIONAL AMENDMENTS TO CERTAIN SENIOR CREDIT INSTRUMENTS

LION ELECTRIC ANNOUNCES THIRD QUARTER 2024 RESULTS RELEASE DATE

LION ELECTRIC ANNOUNCES THIRD QUARTER 2024 RESULTS

LION ELECTRIC ANNOUNCES FURTHER AMENDMENTS TO CERTAIN SENIOR CREDIT INSTRUMENTS

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Lion Electric (LEV.WS)

LION ELECTRIC ANNOUNCES ADDITIONAL AMENDMENTS TO CERTAIN SENIOR CREDIT INSTRUMENTS AND ADDITIONAL WORKFORCE REDUCTIONS

Contracts

LION ELECTRIC REACHES DEFINITIVE AGREEMENT IN RESPECT OF THE SALE OF INNOVATION CENTER LOCATED IN MIRABEL, QUÉBEC

Comments

Lion Electric

Lion Electric (LEV) 옵션

Lion Electric (NYSE:LEV) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌